As of Feb 05
| -1.38 / -2.46%|
The 4 analysts offering 12-month price forecasts for West Pharmaceutical Services Inc have a median target of 64.50, with a high estimate of 69.00 and a low estimate of 59.00. The median estimate represents a +18.00% increase from the last price of 54.66.
The current consensus among 4 polled investment analysts is to Buy stock in West Pharmaceutical Services Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.